Found: 10
Select item for more details and to access through your institution.
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1129, doi. 10.3390/jcm9041129
- By:
- Publication type:
- Article
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.779691
- By:
- Publication type:
- Article
Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5168, doi. 10.3390/cancers13205168
- By:
- Publication type:
- Article
Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3059, doi. 10.3390/cancers13123059
- By:
- Publication type:
- Article
Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3248, doi. 10.3390/cancers12113248
- By:
- Publication type:
- Article
Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4711, doi. 10.1002/cam4.3075
- By:
- Publication type:
- Article
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.736620
- By:
- Publication type:
- Article
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.
- Published in:
- Familial Cancer, 2023, v. 22, n. 1, p. 91, doi. 10.1007/s10689-022-00300-5
- By:
- Publication type:
- Article
Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01311
- By:
- Publication type:
- Article